Patent Assignment
Reel/Frame 043596/0124
Notice of Grant of Security Interest in Patents
Recorded: 2017-08-18
Received: 2017-08-18
Pages: 17
Assignor
MALLINCKRODT LLC
Executed: 2017-08-17
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
60 WALL STREET, NEW YORK, NY, 10005, UNITED STATES
Covered Properties
(17)
Extended Release, Abuse Deterrent Pharmaceutical Compositions
Application:
15/420,386 →
Glucomannan Containing Pharmaceutical Compositions with Extended Release and Abuse Deterrent Properties
Application:
15/417,541 →
Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of Analgesia
Application:
15/385,812 →
Liposomal Elinafide Formulations and Uses Thereof
Application:
62/431,524 →
Mitomycin C Prodrug Liposome Formulations and Uses Thereof
Application:
62/418,950 →
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Application:
15/255,979 →
Substituted Berbines and Processes for Their Synthesis
Application:
15/235,312 →
Two-Step Process for Preparing 3-Substituted Phenylalkylamines
Application:
15/202,670 →
Preparation of Sufentanil Citrate and Sufentanil Base
Application:
15/164,483 →
Combinational Liposome Compositions for Cancer Therapy
Application:
15/162,072 →
Gastric Retentive Extended Release Pharmaceutical Compositions
Application:
15/147,621 →
Extended Release, Abuse Deterrent Solid Dosage Forms
Application:
62/315,952 →
Combination Composition Comprising Oxycodone and Acetaminophen for Rapid Onset and Extended Duration of Analgesia
Application:
15/065,635 →
Functional, Cross-Linked Nanostructures for Tandem Optical Imaging and Therapy
Application:
15/054,739 →
Modified Docetaxel Liposome Formulations and Uses Thereof
Application:
15/046,243 →
Glucomannan Containing Pharmaceutical Compositions with Extended Release and Abuse Deterrent Properties
Application:
62/292,463 →
Compositions Comprising An Opioid And An Additional Active Pharmaceutical Ingredient For Rapid Onset And Extended Duration Of Analgesia That May Be Administered Without Regard To Food
Application:
14/188,582 →